Neuronal and astrocytic protein degradation are critical for fear memory formation

Strong evidence has implicated proteasome-mediated protein degradation in the memory consolidation process. However, due to the use of pharmacological approaches, the cell type specificity of this remains unknown. Here, we used neuron-specific and novel astrocyte-specific CRISPR–dCas9–KRAB–MECP2 plasmids to inhibit protein degradation in a cell type-specific manner in the amygdala of male rats. We found that while inhibition of neuronal, but not astrocytic, protein degradation impaired performance during the training session, both resulted in impaired contextual fear memory retention. Together, these data provide the first evidence of a cell type-specific role for protein degradation in the memory consolidation process.
Funding Information
  • National Institutes of Health (MH122414, MH120498, MH120569, MH123742, AG071523, AG079292)

This publication has 34 references indexed in Scilit: